In Section A, participants will acquire diverse doses and schedules of oral ABBV-744 pill to identify Safe and sound dosing program. Further members are going to be enrolled on the determined monotherapy dosign regimen. In Segment B, members will get oral ruxolitinib and ABBV-744 will be presented as "increase-on" therapy. https://abbv-744-in-acute-myeloid02356.blogproducer.com/38701645/abbv-744-in-combination-with-immunotherapy-an-overview